嬌生Erleada治療mCSPC新適應症三期試驗達終點有望取代 ... | 合法藥品大搜索

CADTH 於2020 年4 月22 日公告之評估報告，pERC 建議收載「apalutamide. （Erleada）合併ADT 用於治療轉移性的去勢敏感性前列腺癌（mCSPC）」，但成. 本 ... Read More

What is ERLEADA®? ERLEADA® (apalutamide) is a prescription medicine used for the treatment of prostate cancer: ... It is not known if ERLEADA® is safe and ... Read More

What is ERLEADA®? ERLEADA® (apalutamide) is a prescription medicine used for the treatment of prostate cancer: ... It is not known if ERLEADA® is safe and ... Read More

What is ERLEADA®? ERLEADA® (apalutamide) is a prescription medicine used for the treatment of prostate cancer: ... It is not known if ERLEADA® is safe and ... Read More

What is ERLEADA®? ERLEADA® (apalutamide) is a prescription medicine used for the treatment of prostate cancer: ... It is not known if ERLEADA® is safe and ... Read More

2019年6月1日 — 除了滿足OS和rPFS的主要雙重終點外，試驗結果還滿足ERleada加ADT治療延長患者化療細胞毒性時間的次要終點。 從另一個角度來看，嬌生的 ... Read More

ERLEADA® (apalutamide) is an androgen receptor inhibitor indicated for the treatment of patients with: Metastatic castration-sensitive prostate cancer (mCSPC) ... Read More

Overview. Erleada is a cancer medicine used to treat men with cancer of the prostate (a gland of the male reproductive system). It is used when the cancer is not ... Read More